Increased frequency of 6-thioguanine-resistant lymphocytes in peripheral blood of workers employed in cyclophosphamide production.
The frequency of 6-thioguanine-resistant peripheral blood lymphocytes has been determined by autoradiography in a control population and a population of cyclophosphamide-exposed individuals. The mean variant frequency in a non-exposed population was found to be 2.76 +/- 1.48 X 10(-5). Subpopulations of smokers and non-smokers revealed statistically significant differences in the variant frequencies, i.e. 3.52 +/- 1.55 X 10(-5) and 2.07 +/- 1.05 X 10(-5) respectively. In 20 out of a total of 23 individuals employed in cyclophosphamide synthesis and manufacturing, the variant frequency of 6-thioguanine-resistant lymphocytes was found to be higher than the maximum individual frequency found in the control population. The mean variant frequency in the cyclophosphamide-exposed population was 13.64 +/- 13.56 X 10(-5), a statistically significant increase as compared to the mean control frequency. There was no correlation between variant frequency and duration of employment suggesting that this test reflects the actual exposure and not a cumulative effect.
Hüttner
E
E
Central Institute of Genetics and Research in Cultivated Plants, Academy of Sciences of the G.D.R., Gatersleben.
Mergner
U
U
Braun
R
R
Schöneich
J
J
D000328:Adult; D001345:Autoradiography; D002469:Cell Separation; D003520:Cyclophosphamide / Q000633:toxicity*; D004351:Drug Resistance / Q000235:genetics; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D009153:Mutagens; D012907:Smoking; D013866:Thioguanine / Q000494:pharmacology*
D009153:Mutagens; D003520:Cyclophosphamide; D007041:Hypoxanthine Phosphoribosyltransferase; D013866:Thioguanine